Ferinject (ferric carboxymaltose) is an intravenous iron replacement therapy used to treat iron deficiency conditions, particularly when oral iron supplements are ineffective, poorly tolerated, or when there is a clinical need to deliver iron rapidly to the body. It is commonly prescribed for patients suffering from iron deficiency anemia, a condition characterized by a lack of red blood cells due to insufficient iron, which can lead to fatigue, weakness, and shortness of breath among other symptoms. Ferinject works by replenishing the body's iron stores, allowing for the production of healthy red blood cells. It is administered directly into the bloodstream by a healthcare professional, ensuring quick absorption and effectiveness. This treatment is particularly beneficial for patients with conditions that inhibit iron absorption or for those who cannot tolerate oral iron supplements.